Suppr超能文献

经导管主动脉瓣植入术后围手术期他汀类药物治疗与短期临床结局的关系:一项回顾性队列研究。

Association between perioperative statin treatment and short-term clinical outcomes following transcatheter aortic valve implantation: a retrospective cohort study.

机构信息

Department of Geriatric Medicine, Utrecht University, Utrecht, The Netherlands

Department of Geriatric Medicine, Utrecht University, Utrecht, The Netherlands.

出版信息

Open Heart. 2023 Oct;10(2). doi: 10.1136/openhrt-2023-002348.

Abstract

BACKGROUND

Studies have found statin treatment to be associated with improved 1-year survival after transcatheter aortic valve implantation (TAVI), suggesting pleiotropic effects of statins on preventing perioperative complications. Statin treatment is not associated with postoperative cardiovascular complications or mortality; however, other postoperative complications have not been investigated.

AIM

To explore whether preoperative statin treatment is associated with a lower short-term risk of mortality, readmission and major postoperative complications in older patients undergoing TAVI.

METHODS

A retrospective cohort study including patients aged 65 years and older who had undergone a comprehensive geriatric assessment prior to TAVI between January 2014 and January 2021. The primary outcomes were 90-day mortality, 90-day readmissions and major postoperative complications according to the Clavien-Dindo classification. Multivariable logistic regression was performed with adjustment for potential confounders, namely age, gender, comorbidity, body mass index, smoking, diminished renal function, alcohol use and falls .

RESULTS

This study included 584 patients, of whom 324 (55.5%) were treated with a statin. In the statin treated group, 15 (4.6%) patients died within 90 days of TAVI compared with 10 (3.8%) patients in the non statin group (adjusted OR 1.17; 95% CI 0.51 to 2.70). The number of 90-day readmissions was 39 (12.0%) and 34 (13.1%) (adjusted OR 0.91; 95% CI 0.54 to 1.52), respectively. In the statin treated group, 115 (35.5%) patients experienced a major complication compared with 98 (37.7%) in the non-statin group (adjusted OR 0.95; 95% CI 0.67 to 1.37).

CONCLUSION

Preoperative statin treatment is not associated with improved short-term outcomes after TAVI. A randomised controlled trial with different statin doses may be warranted to investigate whether initiating statin treatment before TAVI improves both postoperative outcomes and long-term survival.

摘要

背景

研究发现他汀类药物治疗与经导管主动脉瓣植入术(TAVI)后 1 年生存率的提高有关,这表明他汀类药物在预防围手术期并发症方面具有多效性。他汀类药物治疗与术后心血管并发症或死亡率无关;然而,其他术后并发症尚未得到研究。

目的

探讨他汀类药物治疗是否与 TAVI 老年患者的短期死亡率、再入院率和主要术后并发症降低相关。

方法

本研究回顾性纳入了 2014 年 1 月至 2021 年 1 月期间在 TAVI 术前接受全面老年评估的年龄≥ 65 岁患者。主要结局为 90 天死亡率、90 天再入院率和根据 Clavien-Dindo 分类的主要术后并发症。多变量逻辑回归用于调整潜在混杂因素,包括年龄、性别、合并症、体重指数、吸烟、肾功能减退、饮酒和跌倒。

结果

本研究纳入了 584 名患者,其中 324 名(55.5%)接受了他汀类药物治疗。在他汀类药物治疗组中,15 名(4.6%)患者在 TAVI 后 90 天内死亡,而非他汀类药物治疗组中为 10 名(3.8%)(调整后的 OR 1.17;95%CI 0.51 至 2.70)。90 天再入院人数分别为 39 例(12.0%)和 34 例(13.1%)(调整后的 OR 0.91;95%CI 0.54 至 1.52)。在他汀类药物治疗组中,115 名(35.5%)患者发生主要并发症,而非他汀类药物治疗组为 98 名(37.7%)(调整后的 OR 0.95;95%CI 0.67 至 1.37)。

结论

TAVI 术后,术前他汀类药物治疗与短期结局改善无关。可能需要进行随机对照试验,以不同剂量的他汀类药物治疗,来研究 TAVI 前开始他汀类药物治疗是否能改善术后结局和长期生存率。

相似文献

8

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验